Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The Latest Hepatitis C News From the 2018 International Liver Congress
If you have a relatively healthy liver and cleared hepatitis B “e” antigen, is it possible to stop taking hepatitis B antivirals?
The standard treatment duration is 12 or 24 weeks.
An interview with Achim Kautz, special consultant of the European Liver Patients Association and director of the German Liver Help Project
Here is the link to the latest EASL summary of optimum Hep C treatment options for the various genotypes.
Highlights from the 50th Annual Meeting of the European Association for the Study of the Liver include treatments that benefit a wider...
Highlights from the the spring meeting of EASL’s 50th International Liver Congress
NAFLD, liver cancer and new noninvasive liver tests will get more of the research spotlight than ever before.
12 weeks of Merckâ€™s grazoprevir and elbasvir cured hepatitis C in 99 percent of people with genotype 1 of the virus and advanced kidney...
The European Association for the Study of the Liver has issued revised guidelines for the treatment of hepatitis C.
Curing hepatitis C reduces central fatigue, which is weakness originating in the central nervous system.
Twenty-four weeks of Gilead Sciences’ Sovaldi and ribavirin boasted high cure rates among people with genotype 4 of hep C in a recent trial.
Interferon, along with depression and fatigue, is an independent variable that dampens the experience of hepatitis C treatment.
AbbVie’s ’3-D’ regimen has had nearly perfect preliminary results in curing people with recurrent geno 1 of hep C post-liver transplant.
Sovaldi treatment has shown good results curing those who have recurring hepatitis C following a liver transplant.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.